COVID-19 and retinal degenerative diseases: Promising link "Kaempferol".
Curr Opin Pharmacol
; 64: 102231, 2022 06.
Статья
в английский
| MEDLINE | ID: covidwho-1797024
ABSTRACT
Coronavirus disease (COVID-19) outbreak has caused unprecedented global disruption since 2020. Approximately 238 million people are affected worldwide where the elderly succumb to mortality. Post-COVID syndrome and its side effects have popped up with several health hazards, such as macular degeneration and vision loss. It thus necessitates better medical care and management of our dietary practices. Natural flavonoids have been included in traditional medicine and have also been used safely against COVID-19 and several other diseases. Kaempferol is an essential flavonoid that has been demonstrated to influence several vital cellular signaling pathways involved in apoptosis, angiogenesis, inflammation, and autophagy. In this review, we emphasize the plausible regulatory effects of Kaempferol on hallmarks of COVID-19 and macular degeneration.
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Retinal Diseases
/
COVID-19 Drug Treatment
/
Macular Degeneration
Темы:
Длинный Ковид
/
Традиционная медицина
Пределы темы:
Пожилые
/
Люди
Язык:
английский
Журнал:
Curr Opin Pharmacol
Тематика журнала:
Фармакология
Год:
2022
Тип:
Статья
Аффилированная страна:
J.coph.2022.102231
Документы, близкие по теме
MEDLINE
...
LILACS
LIS